Mothers with HIV are at high risk of a range of psychosocial issues that may impact HIV disease progression for themselves and their children. Stigma has also become a substantial barrier to accessing HIV/AIDS care and prevention services. The study objective was to determine the prevalence and severity of postpartum depression (PPD) among women living with HIV and to further understand the impact of stigma and other psychosocial factors in 123 women living with HIV attending prevention of mother-to-child transmission (PMTCT) clinic at Kenyatta National Hospital located in Nairobi, Kenya. We used the Edinburgh Postnatal Depression Scale and HIV/AIDS Stigma Instrument -PLWHA (HASI -P). Forty-eight percent (N = 59) of women screened positive for elevated depressive symptoms. Eleven (9%) of the participants reported high levels of stigma. Multivariate analyses showed that lower education (OR = 0.14, 95% CI [0.04-0.46], p = .001) and lack of family support (OR = 2.49, 95% CI [1.14-5.42], p = .02) were associated with the presence of elevated depressive symptoms. The presence of stigma implied more than ninefold risk of development of PPD (OR = 9.44, 95% CI [1.132-78.79], p = .04). Stigma was positively correlated with an increase in PPD. PMTCT is an ideal context to reach out to women to address mental health problems especially depression screening and offering psychosocial treatments bolstering quality of life of the mother-baby dyad.
Background
Mothers with HIV face a range of psychosocial problems, including postpartum depression (PPD) (Vesga-Lopez et al., 2008) which impacts HIV disease progression in the mother and has lasting impacts for child health (Hartley et al., 2010) . Depression is a highly prevalent co-morbidity among HIV+ individuals (Owe-Larsson, Sall, Salamon, & Allgulander, 2009) . It is inversely correlated with self-esteem, infant health status, and years of formal education (Ross, Sawatphanit, Mizuno, & Keiko, 2011; Cummings & Davies, 1994) . High prevalence of depressive symptoms among pregnant HIV+ women are associated with increased risk of adverse pregnancy outcomes and poor quality of life (Kapetanovic, Dass-Brailsford, Nora, & Talisman, 2014) . Additionally, women with HIV experience lower levels of emotional support available to them (Bonacquisti, Geller, & Aaron, 2014) .
Perinatal depression is reported to be as high as 30-50% in South Africa (Chibanda et al., 2010; Hartley et al., 2011; Rochat, Tomlinson, Barnighausen, Newell, & Stein, 2011; Stewart et al., 2010) . In Nyanza province of Kenya, HIV prevalence is as high as 20.7% in antenatal care settings (Dillabaugh et al., 2012) . Stigma is known as a substantial barrier in adhering to and accessing HIV/ AIDS care. Furthermore, stigma contributes to depressive symptomatology (Rao et al., 2012) compounding the negative impact on women living with HIV.
Methods

Setting and participants
We conducted a cross-sectional study with women attending PMTCT clinic at Kenyatta National Hospital (KNH). The clinic serves an average of 160-240 postnatal women every month who are primarily from urban and peri-urban settlements within Nairobi. Our participants were 18-50 years old postnatal women living with HIV recruited at 8-weeks post-delivery. This allowed time for the PCR testing from 6 weeks onwards to ascertain HIV status of their baby. This study was approved by University of Nairobi/KNH Ethics and Review Committee (ERC no. P171/03/2014). All postnatal women with severe depressive symptoms, suicidal ideation, and alcohol abuse disorder were offered psychosocial support by the researcher and thereafter referred to the Department of Mental health at KNH.
Measurements
We gathered information on participants' socio-demographics (age, marital status, educational level, occupation, and socio-economic status), clinical information, and psychosocial information. Probes were made on quality of support received from family, significant others on alcohol use and experience with domestic violence. We also assessed presence of STIs, HIV status of the child, and breast/formula feeding practice to understand associated challenges better. On hindsight, the response options assessing these associated risks were not as elaborate generating limited information and we do acknowledge this as a limitation of our study. We used the 10-item Edinburgh Postnatal Depression Scale (EPDS) to screen for and examine severity of depressive symptoms (Cox, Holden, & Sagovsky, 1987) . EPDS is an internationally validated tool for identifying patients at risk for perinatal depression and frequently used in sub-Saharan Africa (Tsai et al., 2013) . Women who scored above 12 were identified as having elevated untreated depressive symptoms. HIV/AIDS Stigma Instrument -PLWHA (HASI-P) is a 33-item instrument covering six dimensions of HIV-related stigma: verbal abuse, negative self-perception, and health-care neglect, as well as dimensions such as social isolation, fear of contagion, workplace stigma, and total perceived stigma (Holzemer et al., 2007) . It is built on a 4-point Likert scale with responses ranging from 0 (never) to 3 (mostly). We calculated the median overall stigma and used the median value to categorize the participant to either: 0never, 1once or twice, 2severally, and 3mostly. We found that those with median of 1, 2, and 3 were few and combined them to have a new variable: no stigma and presence of stigma. We found very few responses ranging from once to most options thus we decided to turn stigma from a continuous score into a binary one.
Statistical analysis
We analyzed data using the SPSS version 20. We employed a descriptive univariate analysis to describe the socio-demographics, psychosocial risk factors, and depression prevalence. To test relationships among these variables, we performed bivariate analyses using chi-square/Fisher's exact and Kendall's tau-b tests.
Finally, the multivariate regression model was fitted with depression as an outcome and predictors such as education, family support, and levels of HIV/AIDS stigma that were associated in the bivariate analysis with a p value of .05. All relationships were described with their odds ratio (OR) with their 95% confidence intervals (Table 1) .
Results
Prevalence of PPD
The mean age of women in our study was 31 years (N = 123, SD = 5.2). The EPDS mean score was 11.53 (SD = 5.7) and 59 (48%) of our participants met screening criteria for elevated depressive symptoms. We did find it a matter of concern that 29% (n = 36) of our participants had suicidal ideation (see Table 2 ).
Predictors of PPD among women living with HIV
On multivariate analyses (see Figure 1 ), EPDS score >12 was strongly associated with level of education (x 2 (1) = 13.60, p < .0001). Elevated depressive symptoms were also associated with lack of family support (x 2 (1) = 6.30, p = .012). Elevated depressive symptoms were also associated with overall stigma (x 2 (3) = 9.23, p = .03) and particularly with negative self-perceived stigma type (x 2 (3) = 23.17, p < .0001) where poor selfefficacy is co-terminus with the experience of stigma.
Eleven (9%) of the participants reported high levels of stigma. Multivariate analyses showed that lower education (OR = 0.14, 95% CI [0.04-0.46], p = .001) and lack of family support (OR = 2.49, 95% CI [1.14-5.42], p = .02) were associated with the presence of elevated depressive symptoms. Furthermore, the presence of stigma implied more than ninefold risk of development of PPD (OR = 9.44, 95% CI [1.132-78.79], p = .04).
Discussion
We found a large proportion of postpartum women living with HIV experience elevated depressive symptoms. Family social support, educational level, and stigma are (Fisher et al., 2012; Rao et al., 2012; Kotze, Visser, Makin, Sikkema, & Forsyth, 2013) . PPD was shown to be as high as 30-50% in multiple studies in Africa (Chibanda et al., 2010; Hartley et al., 2011; Rochat et al., 2011; Stewart et al., 2010) . High prevalence of clinically significant depressive symptoms and suicidal ideation reported by women in our study is consistent with studies conducted in the region (Gavin, Tabb, Melville, Guo, & Katon, 2011) . Our findings can be situated along the following themes.
(a) Depression as a significant challenge in HIV-positive women in perinatal spectrum: Fewer studies have been conducted on PPD among women living with HIV (Kaida et al., 2014) . A Ugandan study found 39% of their 447 HIV-positive participants from ages 18 to 49 years screened positive for probable depression (Kersten-Alvarez et al., 2012) . Higher levels of HIV-related stigma were significantly associated with elevated depressive symptoms (Endeshaw et al., 2014) . Thus, intervening at the PMTCT level itself might reduce psychiatric morbidity and improve adherence and engagement in the program (Abrams, Myer, Rosenfield, & El-Sadr, 2007) . (b) Addressing disempowerment and the absence of support at familial and social levels: Our study participants experienced elevated depressive symptoms and a veritable lack of social support. Social support is known as a strong protective factor against PPD (Robertson, Grace, Wallington, & Stewart, 2004) and support from family members acts as a buffer against depression in women in LMIC settings (Broadhead, Abas, Khumalo Sakutukwa, Chigwanda, & Garura, 2001) . Education was positively associated with PPD in that women who report low rates of depressive symptoms comparatively have higher education (Bennetts et al., 1999; Prachakul, Grant, & Keltner, 2007; Rao et al., 2012) . (c) Stigma as a strong determinant of depression in women with HIV: Our results reconfirm that stigma has a strong association with PPD especially in Kenyan cultural context (Dillabaugh et al., 2007) . Both experienced stigma and internalized stigma were strong predictors of PPD among HIV-positive South African women (Peltzer & Shikwane, 2011) .
Other studies in the region too have found that women who had primary education or less have greater adjusted odds of substantial stigma (Cuca, Onono, Bukusi, & Turan, 2012) .
Study limitations
EPDS is a screening instrument and not a clinical tool as such limiting our scope. As a pilot project we did not use elaborate psychometric tools to assess risk factors such as social support, alcohol consumption, and intimate partner violence in great rigor.
Caveats and conclusion
PPD, if left untreated, has adverse effects on mothers and their infants. For the mother, the episode can be the precursor of chronic recurrent depression and for her children PPD can impede their social, emotional, cognitive, and physical development (Logsdon, Wisner, & Pinto-Foltz, 2006) . A concern we noted in our study was select participants' alcohol abuse despite being on anti retro virals. Substance use is one of the known barriers to HIV treatment adherence apart from medication side effects and depression (Berg, Michelson, & Safren, 2007) and is also a correlate of PPD (Rubin Cook et al., 2011) . Our findings point to the high prevalence of PPD in the HIV context. We think that PMTCT might be an ideal context to reach out to women to address mental health problems especially depression screening and offering psychosocial treatments benefitting the mother-baby dyad.
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